Physician

Benjamin L Cho, M.D.

According to 2025 Medicare claims, Benjamin Cho, M.D. (NPI: 1245360759) practices medical oncology in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is ONCOLOGY ASSOCIATES OF OREGON P C (NPI: 1013989854; TIN: 930746296) and primary practice location at 97477-8802.

Cho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 536 traditional Medicare patients, billed 61,721 HCPCS/CPT codes, and received $1,117,764 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,418 prescription claims across 300 beneficiaries totaling $1,853,961 in drug costs, led by Ibrance (Palbociclib). DME data shows 50 claims. Open Payments data shows 99 records totaling $84,836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $705,702 to $1,853,961. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	338	63,091	$855,559
2016	438	109,515	$1,465,619
2017	475	89,218	$1,467,387
2018	432	89,574	$1,347,112
2019	531	101,358	$2,130,695
2020	567	87,268	$1,674,692
2021	544	96,735	$1,686,585
2022	451	95,519	$1,921,912
2023	499	88,858	$1,612,652
2024	536	61,721	$1,117,764

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	223	1,303	$705,702
2016	233	1,460	$974,620
2017	240	1,786	$1,159,604
2018	231	1,545	$1,142,851
2019	267	1,595	$1,590,432
2020	251	1,419	$1,630,480
2021	265	1,442	$1,707,304
2022	287	1,526	$2,287,562
2023	255	1,438	$2,166,906
2024	300	1,418	$1,853,961

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	58	$43,920
2016	N/R	112	$39,530
2017	N/R	26	$8,710
2018	N/R	13	$4,232
2019	N/R	42	$5,336
2020	N/R	52	$4,711
2021	N/R	59	$4,994
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	50	$2,659

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	141	330	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	169	257	$62
80053	Blood test, comprehensive group of blood chemicals	335	782	$10
36415	Insertion of needle into vein for collection of blood sample	349	838	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	347	800	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	27	756	$414,466
Jakafi	Ruxolitinib Phosphate	13	390	$222,704
Eliquis	Apixaban	49	1,599	$33,364
Exemestane	Exemestane	93	5,186	$8,824
Anastrozole	Anastrozole	323	26,406	$5,938

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$1,590
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$579
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$284
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$207

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	99	$84,836	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin L. Cho, M.D.?

Tedicare shows public-source Medicare data for Benjamin L. Cho, M.D. (NPI 1245360759), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin L. Cho, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Benjamin L. Cho, M.D.?

Benjamin L. Cho, M.D. is linked to ONCOLOGY ASSOCIATES OF OREGON P C (billing NPI 1013989854) in the available physician profile data.

Does Benjamin L. Cho, M.D. have Open Payments data?

Benjamin L. Cho, M.D. has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.